Philadelphia ranked seventh in the latest effort to identify the top biopharmaceutical clusters in the United States.
The ranking was put together by Genetic Engineering & Biotechnology News (GEN), an industry trade publication. Here’s what it had to say about the region:
“The birthplace of Liberty has sought to leverage its heritage as a pharma mecca to build a more diverse concentration of biopharma businesses and institutions that has grown to 42,000 jobs (according to regional economic development group Select Greater Philadelphia). Anchors include Philadelphia’s University City Science Center, where earlier this month the University of Pennsylvania agreed to expand to 55,900 square feet in a new office-lab building being co-developed by the center and Wexford Science & Technology. While the region’s NIH grant haul is strong enough to place fourth ($123.4 million), the region was seventh in drawing private capital ($164 million) and in patents (368).” Read more about this story on PBJ.com.